Overview

DoriNano aims to harness the potential of DNA origami technology to develop safe, effective, and low-cost combination nanomedicines that have precise cellular targeting with minimal effective doses of cargo for serious diseases. The company’s platform sets out to solve the past limitations of nanoparticles for delivering therapeutic cargo, offering unique advantages such as programmable size and shape, versatile cargo conjugation, precise nanospacing /stoichiometry controls, low immunogenicity, and flexible storage condition.